Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Boshili Pharmaceutical Technology is a specialized pharmaceutical research and development organization based in Beijing, China, focusing on high-end drug delivery systems and complex formulation technologies. Founded in 2011, the company provides comprehensive CRO and CDMO services, particularly in the solubilization of poorly soluble drugs and the development of sustained and controlled-release preparations. Boshili operates state-of-the-art R&D laboratories and GMP-compliant pilot production lines to support clients through formulation optimization, analytical testing, and clinical trial material manufacturing. Their expertise encompasses a wide range of dosage forms, including injectable emulsions, liposomes, microspheres, and modified-release oral solids, catering to both innovative drug developers and generic pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Boshili Pharmaceutical Technology.